2024-2030 年全球药用辅料市场

由于对改善药物溶解度、稳定性、生物有效性和依从性的辅料的需求不断增加，以患者为中心的配方将经历急剧增长

Frost & Sullivan 的报告分析了全球药用辅料市场，重点关注北美、欧洲、亚太地区、拉丁美洲以及中东和非洲 (MEA) 等主要区域市场。报告对口服辅料、注射辅料、外用辅料、吸入辅料和眼用辅料等各个细分市场进行了定性和定量分析。口服辅料细分市场进一步分为口服固体和口服液体。人口老化和疾病数量的增加推动了所有治疗领域对多样化药物製剂的需求。口服给药因其成本效益和更高的患者依从性而成为最受欢迎的给药方式。然而，预计吸入给药将在预测期内实现最大增长。这项研究提供了对预测期内影响产业的市场动态的透彻理解。它分析了市场成长的驱动因素和限制因素，并确定了该领域变化带来的机会，以便市场参与者和相关人员能够利用这些机会。报告的基准年为2024年，预测期间为2025年至2030年。

目录

成长机会：研究范围

• 分析范围
• 研究范围和细分
• 定义

成长环境：药用辅料市场的转型

• 为何成长变得越来越困难？
• The Strategic Imperative 8（TM）
• 三大策略要务对药用辅料产业的影响

药用辅料市场生态系统

• 价值链
• 竞争环境
• 主要竞争对手
• 竞争基准化分析– 口头（固体）
• 竞争基准化分析－口服给药（液体）
• 竞争基准化分析- 注射剂
• 竞争性基准化分析– 专题
• 竞争基准化分析- 吸入
• 竞争基准化分析- 眼药水
• 市场活动 - 发布、併购、伙伴关係、扩张（2022-2024）

药用辅料市场成长引擎

• 成长指标
• 成长动力
• 成长动力分析
• 成长抑制因素
• 成长抑制因素分析
• 预测考虑因素
• 收益预测
• 收益预测分析
• 按类型分類的收益预测
• 按类型分類的收益预测分析
• 各地区收益预测
• 各地区收益预测分析
• 价格趋势及预测分析
• 收益占有率

生长促进剂：口服给药载体

• 成长指标
• 收益预测
• 收益预测分析
• 按类型分類的收益预测
• 口服固体收益预测（按类型）
• 按子类型分類的收益预测 -粘合剂和填充剂
• 涂料子类型收益预测
• 按子类型分類的收益预测 -崩坏
• 口服固体收益预测（按类型）
• 口服液产品收益预测（按类型）
• 按类型预测 - 口服液
• 各地区收益预测
• 区域预测分析

生长促进剂：注射辅料

• 成长指标
• 收益预测
• 收益预测分析
• 收益预测
• 按类型分類的收益分析 - 注射剂
• 各地区收益预测
• 区域预测分析 - 注射剂

成长动力：热门载体

• 成长指标
• 收益预测
• 收益预测分析
• 收益预测
• 按类型进行预测分析 - 主题
• 各地区收益预测
• 区域预测分析 - 专题

生长促进剂：吸入辅料

• 成长指标
• 收益预测
• 收益预测分析
• 收益预测
• 按类型预测分析 - 吸入
• 各地区收益预测
• 区域预测分析 - 吸入

成长动力：眼科辅料

• 成长指标
• 收益预测
• 收益预测分析
• 收益预测
• 按类型预测分析 - 眼科
• 各地区收益预测
• 区域预测分析 - 眼科

药用辅料市场的成长机会

• 成长机会1：新型辅料开发的独立核准途径
• 成长机会二：吸入式生物製剂
• 成长机会3：以病人为中心的配方

附录与后续步骤

• 成长机会的益处和影响
• 后续步骤Next steps
• 文件清单
• 免责声明

Patient-centric Formulations are Experiencing Transformational Growth Due to Increased Demand for Excipients that Improve Drug Solubility, Stability, Bioavailability, and Compliance

This Frost & Sullivan report analyzes the global pharmaceutical excipients market, with a focus on key regional markets, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa (MEA). The report provides both qualitative and quantitative analyses of various segments, including oral dosage excipients, injectable excipients, topical excipients, inhalable excipients, and ophthalmic excipients. The oral dosage excipients segment is further divided into the oral solid excipients and oral liquid excipients. Population aging, combined with a rising prevalence of diseases, is driving demand for diverse drug dosage formulations across all therapeutic areas. The oral route of drug administration is the most preferred due to its cost-effectiveness and better patient compliance. However, the inhalable route is expected to account for the most significant growth during the forecast period. This study offers a thorough understanding of the market dynamics that will shape the industry over the forecast period. It analyzes the factors driving and restraining market growth and identifies opportunities that arise from the changes in this space for market players and stakeholders to leverage. The base year for this report is 2024, while the forecast period extends from 2025 to 2030.

Table of Contents

Growth Opportunities: Research Scope

• Scope of Analysis
• Scope and Segmentation
• Definitions

Growth Environment: Transformation in the Pharmaceutical Excipients Market

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Pharmaceutical Excipients Industry

Ecosystem in the Pharmaceutical Excipients Market

• Value Chain
• Competitive Environment
• Key Competitors
• Competitive Benchmarking-Oral Solid Dosages
• Competitive Benchmarking-Oral Liquid Dosages
• Competitive Benchmarking-Injectable
• Competitive Benchmarking-Topical
• Competitive Benchmarking-Inhalable
• Competitive Benchmarking-Ophthalmic
• Market Activities-Launches, M&As, Partnerships, and Expansions, 2022-2024

Growth Generators in the Pharmaceutical Excipients Market

• Growth Metrics
• Growth Drivers
• Growth Driver Analysis
• Growth Restraints
• Growth Restraint Analysis
• Forecast Considerations
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast by Type
• Revenue Forecast Analysis by Type
• Revenue Forecast by Region
• Revenue Forecast Analysis by Region
• Pricing Trends and Forecast Analysis
• Revenue Share

Growth Generator: Oral Dosage Excipients

• Growth Metrics
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast by Type
• Revenue Forecast by Type-Oral Solids
• Revenue Forecast by Sub-type-Binders and Fillers
• Revenue Forecast by Sub-type-Coatings
• Revenue Forecast by Sub-type-Disintegrants
• Forecast Analysis by Type-Oral Solids
• Revenue Forecast by Type-Oral Liquids
• Forecast Analysis by Type-Oral Liquids
• Revenue Forecast by Region
• Forecast Analysis by Region

Growth Generator: Injectable Excipients

• Growth Metrics
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast
• Forecast Analysis by Type-Injectables
• Revenue Forecast by Region
• Forecast Analysis by Region-Injectables

Growth Generator: Topical Excipient

• Growth Metrics
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast
• Forecast Analysis by Type-Topical
• Revenue Forecast by Region
• Forecast Analysis by Region-Topical

Growth Generator: Inhalable Excipients

• Growth Metrics
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast
• Forecast Analysis by Type-Inhalable
• Revenue Forecast by Region
• Forecast Analysis by Region-Inhalable

Growth Generator: Ophthalmic Excipients

• Growth Metrics
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast
• Forecast Analysis by Type-Ophthalmic
• Revenue Forecast by Region
• Forecast Analysis by Region-Ophthalmic

Growth Opportunity Universe in the Pharmaceutical Excipients Market

• Growth Opportunity 1: Independent Approval Pathway for the Development of Novel Excipients
• Growth Opportunity 2: Inhaled Biologics
• Growth Opportunity 3: Patient-centric Formulations

Appendix & Next Steps

• Benefits and Impacts of Growth Opportunities
• Next Steps
• List of Exhibits
• Legal Disclaimer